Headlines From "The Pink Sheet" DAILY

Senate HELP Committee Leadership: Sizing Up The Candidates

Regardless who is chosen as chairman, the committee will undoubtedly feel in the near-term the absence of a champion of federal health programs - one who is both forceful in demeanor and expert in the detailed workings and policy history of a variety of initiatives.   read more

 

Trubion Finds Kindred Spirit in Facet For Co-Development And Commercialization

Recently launched spinout from PDL BioPharma pays $20 million upfront to Trubion for chronic lymphocytic leukemia candidate.   read more

 

Can Tricky Elderly AML Population Justify Weak Data? Fate Of Genzyme's Clolar and Vion's Onrigin Rests With ODAC

FDA's briefing documents for the Sept. 1 review suggest the single-arm Phase II trials are not sufficient; the wild card will be whether the panel thinks better trials can be done in that population.   read more

 

Leading Chinese Biotech Firm 3SBio Lays Groundwork For Foray Into Biosimilars In U.S., EU Markets

New biologics plant will quadruple the firm's capacity by the end of the year, enabling commercialization of biosimilars in more developed countries and markets, COO says.   read more

 

Value-Based Insurance In Public Plan Could Change Approach To Rx Copays

House health care reform bill would introduce the concept of value-based purchasing into the proposed public plan option.   read more

 

"The Pink Sheet" DAILY is the leading on-line news and analysis service for the pharmaceutical industry. For information about a subscription or to sign up for a free trial, click here.